Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Wellness BioSciences Rx
WARNING LETTER
•Wellness BioSciences Rx•December 22, 2020

Wellness BioSciences Rx – FDA Warning Letter, Dec 22, 2020

Record Details

The FDA issued a Warning Letter to WBRx Global on December 22, 2020, following a review of their websites in September and December 2020. The FDA observed that WBRx Global sells various CBD products, including "WBRx Metered-Dose Inhaler," "WBRx Balance Softgels CBD," "WBRx Pure Wellness CBD," "WBRx Energy Oil Drops CBD," and "WBRx Sleep Oil Drops CBD."

The FDA determined that these CBD products are unapproved new drugs, sold in violation of sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d), due to drug claims on their website and social media. Specifically, the "WBRx Metered-Dose Inhaler" is of particular concern due to potential inhalation risks. The products are also deemed misbranded drugs under section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1), for lacking adequate directions for use and for misleading claims suggesting FDA approval.

Furthermore, "WBRx Balance Softgels CBD," "WBRx Energy Oil Drops CBD," and "WBRx Sleep Oil Drops CBD" are considered adulterated human foods under

Company
Wellness BioSciences Rx
Inspection date
December 22, 2020
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Donald D. Ashley (Director)
  • William A. Correll (Director)
View Company Profile

ID · 737dd2f4-ce31-4bcd-8480-759b746bc4e7

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21 U.S.C. 331(ll)21 U.S.C. 348(a)21 U.S.C. 342(a)(2)(C)(i)FD&C Act 201(g)(1)FD&C Act 201(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wellness BioSciences Rx
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.